Surgeons must balance research and medical training with outstanding patient care

Like a juggler keeping multiple plates in the air, a surgeon in academic medicine must balance research and medical training with outstanding patient care. Charles Bellows, MD, FACS, relishes the challenge. Dr. Bellows, a University of New Mexico Professor of General Surgery, recently assumed the role of Chief of the Division of General Surgery in the Department of Surgery at the UNM School of Medicine. "Each part of my career has been great, but I was certainly looking for the next career challenge. The opportunity to lead the Division of General Surgery at UNM and focus on designing new delivery models of care, expanding capacity, and educating physicians to excel within a transformed healthcare environment is really exciting," he says.

As Division Chief, Dr. Bellows is responsible for UNM Hospital's Level I Trauma Center, the only Level I Trauma Center in New Mexico. But also as Division Chief, he will work to expand the clinical and research programs. "As physicians, we must always strive to provide the best possible care for our patients," he explains. And to provide the best possible care, Dr. Bellows believes in innovating. He wants to inspire the Division to find better ways to care for patients every day and improve their outcomes through integrated clinical practice, education and research. Dr. Bellows is looking forward to his new role. "As Division chief, one of the challenges for me will be to create a balance in the Division that fosters research, education and clinical work in a way that makes the workplace environment conducive to innovation, enthusiasm, and commitment," he says. Dr. Bellows believes that a strong academic research program in General Surgery is very important. He will continue his basic and clinical research to set the tone for the whole Division.

One of Dr. Bellows' research areas is biofilm infections and chronic non-healing wounds. Biofilms are thin films of microbes and their sticky secretions that can form over a wound. The body's immune system doesn't fight biofilms well. Biofilms keep wounds from healing and can cause them to become infected, making them difficult and costly to treat. Dr. Bellows' research has shown that re-programmed bone marrow stem cells can produce proteins that destroy biofilms and speed wound healing. Creating methods to safely and effectively deliver these proteins to biofilm-infected wounds in people is the next step in his translational research project.

Another of Dr. Bellow's research areas is obesity and colon cancer. He and his colleagues at University of Texas have recently discovered that obese people and people with colon cancer have high levels of adult fat stem cells in their blood. When the researchers compared the blood of obese and lean people with colon cancer, they found that the obese people had much higher levels of adult fat stem cells. Dr. Bellows and his team are now studying whether and how changing the level of adult fat stems cells in the blood of the obese people affects their colon cancer. Dr. Bellows' particular interest is in how diet and exercise affect colon cancer and whether the level of adult fat stem cells changes.

Dr. Bellows encourages his fellow faculty members to pursue their own research interests and to involve medical students and residents. For faculty, studying an area that interests them can be a refreshing change from their clinical tasks. For students and residents, learning how to balance research with treating people is a critical skill that will serve them well throughout their careers. "The academic mission is critically important for all of us," Dr. Bellows says. "There are many exciting and demanding challenges that lie ahead and I am excited about facing these challenges and making a positive contribution to the University."

Source UNM Cancer Center

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Monitoring cellular metabolism for NAFLD/NASH liver disease research